Evidence map›Paper›PMID 39763627›Full record

ArticleRSC advances2025

An eco-friendly and cost-effective approach for the synthesis of a novel GA@CuO-ZnO nanocomposite: characterization, antimicrobial and anticancer activities.

Gharieb S El-Sayyad, El-Sayed R El-Sayed, Samar H Rizk, Mostafa A Abdel-Maksoud, Adel M Zakri, Abdul Malik, Mohamed N Malash, Amr H Hashem

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gharieb S El-SayyadMedical Laboratory Technology Department, Faculty of Applied Health Sciences Technology, Badr University in Cairo (BUC) Badr city Cairo 11829 Egypt Gharieb.El-Saied@buc.edu.eg.ORCID https://orcid.org/0000-0001-5410-7936
El-Sayed R El-SayedDepartment of Food Chemistry and Biocatalysis, Wrocław University of Environmental and Life Sciences Norwida 25 50-375 Wrocław Poland.
Samar H RizkDepartment of Biochemistry, Faculty of Pharmacy, Ahram Canadian University (ACU) Giza Egypt.
Mostafa A Abdel-MaksoudDepartment of Botany and Microbiology, College of Science, King Saud University P.O. Box 2455 Riyadh 11451 Saudi Arabia.
Adel M ZakriPlant Production Department, College of Food and Agricultural Sciences, King Saud University Saudi Arabia.
Abdul MalikDepartment of Pharmaceutics, College of Pharmacy, King Saud University Saudi Arabia.
Mohamed N MalashMicrobiology and Immunology Department, Faculty of Pharmacy, Ahram Canadian University (ACU) 6th October City Giza Egypt.
Amr H HashemBotany and Microbiology Department, Faculty of Science, Al-Azhar University Nasr City Cairo 11884 Egypt amr.hosny86@azhar.edu.eg.ORCID https://orcid.org/0000-0002-0024-3606

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, a nanocomposite based on copper oxide-zinc oxide nanoparticles and Gum Arabic (GA@CuO-ZnO nanocomposite) was successfully synthesized using green method. Characterization results revealed that the prepared nanocomposite appeared at the nanoscale level, showed excellent dispersion, and formed stable colloidal nano-solutions. The bimetallic GA@CuO-ZnO nanocomposite was evaluated for its anticancer, antibacterial, and antifungal properties. Cytotoxicity testing of the synthesized GA@CuO-ZnO nanocomposite against Wi38 and Vero normal cell lines showed IC

Identifiers

PMID39763627
PMCPMC11701889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.